Retatrutide (formerly M25) is a next-generation multiagonist peptide targeting GLP-1, GIP, and glucagon receptors. Designed to address metabolic dysfunction at multiple regulatory nodes, it modulates appetite, glycemic control, and energy expenditure—positioning it as a promising candidate for significant weight reduction, improved insulin sensitivity, and comprehensive metabolic restoration.
Retatrutide 10mg 10mL Vial
$800.00
-
Description
-
Benefits
- Weight lossÂ
- Appetite suppression
- Improved glucose and insulin sensitivity control
- Enhanced energy expenditure
- Potential reduction in liver fat
- Potential cardiovascular benefits
- Preservation of lean mass
-
Dosing
- 500mcg to full dose 10mgÂ
- Microdose: 500mcg-900mcg once weeklyÂ
- 10 units (500mcg)
- 12 units (600mcg)
- 14 units (700mcg)
- 16 units (800mcg)
- 18 units (900mcg)
- Basic Dosing: 1mg up to 5mg once weeklyÂ
- 20 units = 1mgÂ
- 40 units = 2mgÂ
- 60 units = 3mgÂ
- 80 units = 4mgÂ
- 100 units = 5mg     Â
- 200 units = 10mg      Â
- Microdose: 500mcg-900mcg once weeklyÂ
- 500mcg to full dose 10mgÂ
-
How to Use
- Duration: Please consult with RN specialist for titration schedule
- Administer on the same day each week
- Add 2mL BAC water to the 10mg vial of Retatrutide
- Subcutaneous injection
-
More Information
- What’s included:
- One vial, concentration: 10mg/2mL
- Reconstitution kit
- (20) 27-30G subq needles
- (1) 5mL syringe
- (1) 25G needle with syringe
- (1) 10 mL Bacteriostatic water
- Stacking: Oral BPC-157, Tesamorelin, Ipamorelin, CJC-1295, MOTS-C, 5 Amino-1MQ
